| |
 |
|
Class Information
Number: 514/44
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring > Polynucleotide (e.g., rna, dna, etc.)
Description:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7538095 |
Genetic inhibition by double-stranded RNA |
May. 26, 2009 |
| 7538083 |
Compositions and methods for the potentiation of immune responses against target antigens |
May. 26, 2009 |
| 7534775 |
Methods and compositions for modulating cardiac contractility |
May. 19, 2009 |
| 7534774 |
Traversal of nucleic acid molecules through a fluid space and expression in repair cells |
May. 19, 2009 |
| 7534773 |
TRPM-2 antisense therapy |
May. 19, 2009 |
| 7534772 |
Methods for enhancing antibody-induced cell lysis and treating cancer |
May. 19, 2009 |
| 7534769 |
Compositions and methods for enhancing delivery of therapeutic agents to cells |
May. 19, 2009 |
| 7534613 |
Methods of treating parkinson's disease using viral vectors |
May. 19, 2009 |
| 7531524 |
Modulators of coagulation factors with enhanced stability |
May. 12, 2009 |
| 7531523 |
Sodium channel protein type III alpha-subunit splice variant |
May. 12, 2009 |
| 7531522 |
Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
May. 12, 2009 |
| 7531500 |
Preventing airway mucus production by administration of EGF-R antagonists |
May. 12, 2009 |
| 7531304 |
Method for screening FGFR-4 agonists |
May. 12, 2009 |
| 7531182 |
Vaccine against foot-and-mouth disease |
May. 12, 2009 |
| 7528118 |
RNAi modulation of ApoB and uses thereof |
May. 5, 2009 |
| 7528117 |
High efficacy antisense RI.sub..alpha.PKA poly-DNP oligoribonucleotides |
May. 5, 2009 |
| 7528116 |
Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis |
May. 5, 2009 |
| 7528106 |
Compositions and methods for treatment of neovascular diseases |
May. 5, 2009 |
| 7527800 |
Influenza hemagglutinin and neuraminidase variants |
May. 5, 2009 |
| 7525011 |
Transgenic cancer models in fish |
Apr. 28, 2009 |
| 7524872 |
Method and composition for treating cancer using cellular organelle crystallizing agents |
Apr. 28, 2009 |
| 7524830 |
Decoy-containing pharmaceutical compositions and method of using the same |
Apr. 28, 2009 |
| 7524829 |
Antisense antiviral compounds and methods for treating a filovirus infection |
Apr. 28, 2009 |
| 7524828 |
Immunostimulatory nucleic acid molecules |
Apr. 28, 2009 |
| 7524827 |
Methods and compositions for the inhibition of gene expression |
Apr. 28, 2009 |
| 7524826 |
Method of inhibiting the generation of active thrombin on the surface of a cell within an atherosclerotic plaque |
Apr. 28, 2009 |
| 7524675 |
Pharmaceutical use of alpha antigen or alpha antigen gene |
Apr. 28, 2009 |
| 7524674 |
Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals |
Apr. 28, 2009 |
| 7524510 |
Alkyl-glycoside enhanced vaccination |
Apr. 28, 2009 |
| 7524490 |
Clusterin-mediated inhibition of apoptosis via stromal bone marrow cell delivery to a cardiac site |
Apr. 28, 2009 |
| 7521431 |
Compositions and methods for siRNA inhibition of HIF-1 alpha |
Apr. 21, 2009 |
| 7521239 |
Photochemical internalization for virus-mediated molecule delivery into the cyosol |
Apr. 21, 2009 |
| 7521191 |
siRNA targeting connexin 43 |
Apr. 21, 2009 |
| 7521063 |
Multiple CPG oligodeoxynucleotides and their use to induce an immune response |
Apr. 21, 2009 |
| 7521043 |
Gene therapy for tumors using minus-strand RNA viral vectors encoding immunostimulatory cytokines |
Apr. 21, 2009 |
| 7517866 |
LIM mineralization protein splice variants |
Apr. 14, 2009 |
| 7517865 |
RNAi modulation of RSV and therapeutic uses thereof |
Apr. 14, 2009 |
| 7517864 |
RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
Apr. 14, 2009 |
| 7517863 |
Enhanced secretion/retention of growth hormone releasing hormone (GHRH) from muscle cells by species-specific signal peptide |
Apr. 14, 2009 |
| 7517862 |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
Apr. 14, 2009 |
| 7517861 |
Immunostimulatory nucleic acid molecules |
Apr. 14, 2009 |
| 7517860 |
Inhibition of lipoprotein secretion |
Apr. 14, 2009 |
| 7517683 |
HIV-like particles and the use thereof |
Apr. 14, 2009 |
| 7517644 |
Method and compositions for cellular reprogramming |
Apr. 14, 2009 |
| 7517538 |
Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof |
Apr. 14, 2009 |
| 7514595 |
Targeted and regional cellular ablation in zebrafish |
Apr. 7, 2009 |
| 7514416 |
Interferon alpha and antisense K-ras RNA combination gene therapy |
Apr. 7, 2009 |
| 7514415 |
Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides |
Apr. 7, 2009 |
| 7514414 |
Suppressors of CpG oligonucleotides and methods of use |
Apr. 7, 2009 |
| 7514098 |
Use of targeted cross-linked nanoparticles for in vivo gene delivery |
Apr. 7, 2009 |
|
|
|
